These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 28601767)

  • 1. Pooled human liver preparations, HepaRG, or HepG2 cell lines for metabolism studies of new psychoactive substances? A study using MDMA, MDBD, butylone, MDPPP, MDPV, MDPB, 5-MAPB, and 5-API as examples.
    Richter LHJ; Flockerzi V; Maurer HH; Meyer MR
    J Pharm Biomed Anal; 2017 Sep; 143():32-42. PubMed ID: 28601767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New psychoactive substances: Studies on the metabolism of XLR-11, AB-PINACA, FUB-PB-22, 4-methoxy-α-PVP, 25-I-NBOMe, and meclonazepam using human liver preparations in comparison to primary human hepatocytes, and human urine.
    Richter LHJ; Maurer HH; Meyer MR
    Toxicol Lett; 2017 Oct; 280():142-150. PubMed ID: 28782580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tools for studying the metabolism of new psychoactive substances for toxicological screening purposes - A comparative study using pooled human liver S9, HepaRG cells, and zebrafish larvae.
    Richter LHJ; Herrmann J; Andreas A; Park YM; Wagmann L; Flockerzi V; Müller R; Meyer MR
    Toxicol Lett; 2019 May; 305():73-80. PubMed ID: 30682400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diphenidine, a new psychoactive substance: metabolic fate elucidated with rat urine and human liver preparations and detectability in urine using GC-MS, LC-MS
    Wink CS; Michely JA; Jacobsen-Bauer A; Zapp J; Maurer HH
    Drug Test Anal; 2016 Oct; 8(10):1005-1014. PubMed ID: 26811026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to Study the Metabolism of New Psychoactive Substances for the Purpose of Toxicological Screenings-A Follow-Up Study Comparing Pooled Human Liver S9, HepaRG Cells, and Zebrafish Larvae.
    Wagmann L; Frankenfeld F; Park YM; Herrmann J; Fischmann S; Westphal F; Müller R; Flockerzi V; Meyer MR
    Front Chem; 2020; 8():539. PubMed ID: 32766204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LC-high resolution-MS/MS for identification of 69 metabolites of the new psychoactive substance 1-(4-ethylphenyl-)-N-[(2-methoxyphenyl)methyl] propane-2-amine (4-EA-NBOMe) in rat urine and human liver S9 incubates and comparison of its screening power with further MS techniques.
    Caspar AT; Westphal F; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2018 Jan; 410(3):897-912. PubMed ID: 28762065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elucidation of the metabolites of the novel psychoactive substance 4-methyl-N-ethyl-cathinone (4-MEC) in human urine and pooled liver microsomes by GC-MS and LC-HR-MS/MS techniques and of its detectability by GC-MS or LC-MS(n) standard screening approaches.
    Helfer AG; Turcant A; Boels D; Ferec S; Lelièvre B; Welter J; Meyer MR; Maurer HH
    Drug Test Anal; 2015 May; 7(5):368-75. PubMed ID: 24953431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzofuran analogues of amphetamine and methamphetamine: studies on the metabolism and toxicological analysis of 5-APB and 5-MAPB in urine and plasma using GC-MS and LC-(HR)-MS(n) techniques.
    Welter J; Kavanagh P; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2015 Feb; 407(5):1371-88. PubMed ID: 25471293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxicity of new psychoactive substances and other drugs of abuse studied in human HepG2 cells using an adopted high content screening assay.
    Richter LHJ; Beck A; Flockerzi V; Maurer HH; Meyer MR
    Toxicol Lett; 2019 Feb; 301():79-89. PubMed ID: 30465810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biotransformation and detectability of the new psychoactive substances N,N-diallyltryptamine (DALT) derivatives 5-fluoro-DALT, 7-methyl-DALT, and 5,6-methylenedioxy-DALT in urine using GC-MS, LC-MS
    Michely JA; Brandt SD; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2017 Feb; 409(6):1681-1695. PubMed ID: 27933361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic fate of desomorphine elucidated using rat urine, pooled human liver preparations, and human hepatocyte cultures as well as its detectability using standard urine screening approaches.
    Richter LH; Kaminski YR; Noor F; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2016 Sep; 408(23):6283-94. PubMed ID: 27372715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolic fate of two new psychoactive substances - 2-aminoindane and N-methyl-2-aminoindane - studied in vitro and in vivo to support drug testing.
    Manier SK; Felske C; Eckstein N; Meyer MR
    Drug Test Anal; 2020 Jan; 12(1):145-151. PubMed ID: 31667988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of GSH-trapped reactive metabolites in human liver microsomes, S9 fraction, HepaRG-cells, and human hepatocytes.
    Lassila T; Rousu T; Mattila S; Chesné C; Pelkonen O; Turpeinen M; Tolonen A
    J Pharm Biomed Anal; 2015 Nov; 115():345-51. PubMed ID: 26263063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different in vitro and in vivo tools for elucidating the human metabolism of alpha-cathinone-derived drugs of abuse.
    Manier SK; Richter LHJ; Schäper J; Maurer HH; Meyer MR
    Drug Test Anal; 2018 Jan; ():. PubMed ID: 29314710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Hepatic HepaRG Cells Maintain an Organotypic Phenotype with High Intrinsic CYP450 Activity/Metabolism and Significantly Outperform Standard HepG2/C3A Cells for Pharmaceutical and Therapeutic Applications.
    Nelson LJ; Morgan K; Treskes P; Samuel K; Henderson CJ; LeBled C; Homer N; Grant MH; Hayes PC; Plevris JN
    Basic Clin Pharmacol Toxicol; 2017 Jan; 120(1):30-37. PubMed ID: 27285124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism and cytotoxicity studies of the two hallucinogens 1cP-LSD and 4-AcO-DET in human liver and zebrafish larvae models using LC-HRMS/MS and a high-content screening assay.
    Gampfer TM; Schütz V; Schippers P; Rasheed S; Baumann J; Wagmann L; Pulver B; Westphal F; Flockerzi V; Müller R; Meyer MR
    J Pharm Biomed Anal; 2024 Aug; 245():116187. PubMed ID: 38692215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro studies on flubromazolam metabolism and detection of its metabolites in authentic forensic samples.
    Noble C; Mardal M; Bjerre Holm N; Stybe Johansen S; Linnet K
    Drug Test Anal; 2017 Aug; 9(8):1182-1191. PubMed ID: 27935260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmortem distribution and redistribution of MDAI and 2-MAPB in blood and alternative matrices.
    Staeheli SN; Boxler MI; Oestreich A; Marti M; Gascho D; Bolliger SA; Kraemer T; Steuer AE
    Forensic Sci Int; 2017 Oct; 279():83-87. PubMed ID: 28850871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From street to lab: in vitro hepatotoxicity of buphedrone, butylone and 3,4-DMMC.
    Roque Bravo R; Carmo H; Valente MJ; Silva JP; Carvalho F; Bastos ML; Dias da Silva D
    Arch Toxicol; 2021 Apr; 95(4):1443-1462. PubMed ID: 33550444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of metabolites by an automated online metabolism method using human liver microsomes with subsequent identification by LC-MS(n), and metabolism of 11 cathinones.
    Mueller DM; Rentsch KM
    Anal Bioanal Chem; 2012 Feb; 402(6):2141-51. PubMed ID: 22231510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.